Effect of body habitus and parity on the initial Veres intraperitoneal CO2 insufflation pressure during laparoscopic access in women

Journal of Minimally Invasive Gynecology
Angelos G VilosMohammad Al-Omran

Abstract

Since most gynecologists use the Veres/trocar entry, and because the Veres intraperitoneal (VIP) pressure appears to be the most reliable indicator of correct Veres needle placement, the objective of this study was to determine the effect of height, weight, body mass index (BMI), parity, and age on the initial Veres intraperitoneal CO2 insufflation pressure during laparoscopic access in women. Prospective observational cohort study (Canadian Task Force classification II-1). University affiliated teaching hospital. We prospectively collected data on 356 women undergoing laparoscopy for a variety of indications by the senior author (G.A.V.). The median and (range) for height, weight, BMI, parity, and age were 1.64 m (1.45-1.85 m), 65 kg (40-120 kg), 24.3 kg/m2 (16-47 kg/m2), 1 (0-5) and 34 years (18-87 yrs), respectively. Under general endotracheal anesthesia including muscle relaxants and with the patient in appropriate stirrups in the horizontal position, a nondisposable Veres needle was inserted at the umbilicus or left upper quadrant (Palmer's point) with CO2 flowing at 1 L/min. The initial Veres intraperitoneal insufflation pressure was recorded once the Veres needle was believed to be in the peritoneal cavity. The mode and ...Continue Reading

References

Jan 1, 1989·Acta Obstetricia Et Gynecologica Scandinavica·S E BaadsgaardK Egeblad
Jul 1, 1985·Obstetrical & Gynecological Survey·M OhlgisserM Heifetz
Jan 1, 1987·Acta Obstetricia Et Gynecologica Scandinavica·D Bergqvist, A Bergqvist
Aug 1, 1995·Current Opinion in Obstetrics & Gynecology·D Querleu, C Chapron
Jan 1, 1997·Obstetrics and Gynecology·P Härkki-Sirén, T Kurki
Aug 1, 1997·Surgical Endoscopy·A M Ternamian
Mar 26, 1998·Obstetrical & Gynecological Survey·D M RosenG M Cario
May 16, 1998·Journal of the American College of Surgeons·G KazemierH J Bonjer
Aug 25, 1999·The Journal of the American Association of Gynecologic Laparoscopists·R PasicW M Wolf
Aug 28, 2002·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·George A Vilos
May 21, 2005·Journal of Minimally Invasive Gynecology·Bobby TeohJason Abbott
Dec 13, 2005·Journal of Minimally Invasive Gynecology·Basim Abu-RafeaMohamad Al-Omran

❮ Previous
Next ❯

Citations

Jul 16, 2008·Surgical Endoscopy·George A VilosFawaz Edris
Jul 22, 2011·Canadian Journal of Surgery. Journal Canadien De Chirurgie·Christopher CompeauArtin Ternamian
Sep 30, 2014·European Journal of Obstetrics, Gynecology, and Reproductive Biology·H O TopçuM Doganay
Jan 17, 2012·Journal of Minimally Invasive Gynecology·Angus J M ThomsonJason A Abbott
Aug 3, 2010·Obstetrics and Gynecology Clinics of North America·Stephanie D PickettWilliam W Hurd
May 16, 2006·Journal of Minimally Invasive Gynecology·Basim Abu-RafeaMohammad Al-Omran
Apr 28, 2016·European Journal of Obstetrics, Gynecology, and Reproductive Biology·UNKNOWN Taskforce for Abdominal Entry:
Mar 17, 2015·Best Practice & Research. Clinical Obstetrics & Gynaecology·K AforsA Wattiez
Mar 8, 2017·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Ali AkkocAhmet Metin
May 16, 2006·Journal of Minimally Invasive Gynecology·George A Vilos
Dec 30, 2020·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·George A VilosNicholas Leyland
Dec 30, 2020·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·George A VilosNicholas Leyland
Aug 25, 2019·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Paul J YongCatherine Allaire
Aug 25, 2019·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Paul J YongCatherine Allaire

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.